Protagonist Therapeutics Inc - Company Profile

Powered by

All the data and insights you need on Protagonist Therapeutics Inc in one report.

$ $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date Protagonist Therapeutics Inc Strategy Report

  • Understand Protagonist Therapeutics Inc position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Protagonist Therapeutics Inc: Overview

Select Item

Protagonist Therapeutics Inc (Protagonist) is a clinical-stage biopharmaceutical company that discovers and develops orally stable peptides as targeted therapies. The company through its proprietary technology platform develops structurally novel oral or injectable peptides for protein-protein interaction targets. Its peptides specifically target biological pathways that are also targeted by currently marketed injectable antibody drugs. Protagonist’ product candidates are intended for the treatment of inflammatory bowel disease and other gastrointestinal diseases and hematological disorders. The company has its operations in the US and Australia. Protagonist is headquartered in Milpitas, California, the US.

 Gain a 360-degree view of Protagonist Therapeutics Inc and make more informed decisions for your business Gain a 360-degree view of Protagonist Therapeutics Inc and make more informed decisions for your business Find out more
Headquarters United States of America
Address 7707 Gateway Blvd Ste 140, Newark, California, 94560-1160
Website www.protagonist-inc.com
Telephone 1 510 4740170
No of Employees 112
Industry Pharmaceuticals and Healthcare
Ticker Symbol & Exchange PTGX (NASD)
Revenue (2022) $60.0M 125.7% (2022 vs 2021)
EPS XYZ
Net Income (2022) XYZ 38% (2022 vs 2021)
Market Cap* $1.5B
Net Profit Margin (2022) XYZ 72.5% (2022 vs 2021)
* As of and is in US$
View Protagonist Therapeutics Inc financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Protagonist Therapeutics Inc premium industry data and analytics

50+

Catalyst Calendar

Proactively evaluate Protagonist Therapeutics Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

40+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Protagonist Therapeutics Inc’s relevant decision makers and contact details.

20+

Clinical Trials

Determine Protagonist Therapeutics Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

16+

Pipeline Drugs

Identify which of Protagonist Therapeutics Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

7

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

5

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

Products and Services

Products
Pipeline
PTG-300:
Beta- Thalassemia
XYZ
XYZ
XYZ
Understand Protagonist Therapeutics Inc portfolio and identify potential areas for collaboration Understand Protagonist Therapeutics Inc portfolio and identify potential areas for collaboration Find out more
Image for loader

Competitor Comparison

Key Parameters Protagonist Therapeutics Inc UCB SA Rigel Pharmaceuticals Inc Arena Pharmaceuticals Inc Janssen Pharmaceuticals Inc
Headquarters United States of America Belgium United States of America United States of America United States of America
City Newark Anderlecht South San Francisco San Diego Titusville
State/Province California - California California New Jersey
No. of Employees 112 9,083 147 448 10,400
Entity Type Public Public Public Private Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Harold E. Selick Chairman Executive Board 2017 68
Dinesh V. Patel Chief Executive Officer; Director; President Executive Board 2008 66
Asif Ali Chief Financial Officer; Executive Vice President Senior Management 2022 49
Mohammad Masjedizadeh Chief Technology Officer; Executive Vice President Senior Management 2021 -
Arturo Molina Chief Medical Officer Senior Management 2022 64
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Protagonist Therapeutics Inc key executives to enhance your sales strategy Gain insight into Protagonist Therapeutics Inc key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward